Funding
Turn ideas into impact
Show Me
Due: February 11, 2027
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Type
Cooperative Agreement
Source
Federal
Opp Number
RFA-CA-28-004
Due: February 11, 2027
Accelerating Research and Development of Next Generation Vaccines against Malaria – a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-AI-28-024
Due: April 26, 2027
Notice of Intent to Issue NOFO DE-FOA-0003649: Leveraging Domestic Infrastructure and Resources to Unleash Alternative Chemicals, Fuels and Feedstocks
Type
Other
Source
Federal
Opp Number
DE-FOA-0003648
Due: September 30, 2028
FY 2027-2028 NESDIS Broad Agency Announcement (BAA)
Type
Cooperative Agreement
Source
Federal
Opp Number
NOAA-NESDIS-NESDISPO-2027-33921
Due: October 13, 2028
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
US $2,180,000 – $6,444,000
Type
Grant
Source
Federal
Opp Number
RFA-HL-27-010
Due: March 1, 2029
NIAMS P30 Centers Program (P30 – Clinical Trial Not Allowed)
US $500,000
Type
Grant
Source
Federal
Opp Number
RFA-AR-28-001
Due: May 25, 2029
NIH Research Program Projects (Parent P01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PA-27-061
Due: September 25, 2029
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-28-022
Due: September 26, 2029
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-27-003
Do you have a grant, incentive, funding competition, or other funding source to share?